Email xiey1@sloankettering.edu Dissertation Genetic Loss-of-Function Studies of SETD2 in Tumorigenesis (2020) Mentor Emily H. Cheng, MD, PhD Start Year 2014 End Year 2020 Education BS, Tsinghua University Fellowships NCI Predoctoral to Postdoctoral Fellow Transition Award (NCI F99/K00 -2018-2020) Olayan Fellowship (2015-2016) Publications Tanaka K, Yu HA, Yang S, Han S, Selcuklu SD, Kim K, Ramani S, Ganesan YT, Moyer A, Sinha S, Xie Y, Ishizawa K, Osmanbeyoglu HU, Lyu Y, Roper N, Guha U, Rudin CM, Kris MG, Hsieh JJ, Cheng EH. (2021) Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis. Cancer Cell. Nargund AM, Pham CG, Dong Y, Wang PI, Osmangeyoglu HU, Xie Y, Aras O, Han S, Oyama T, Takeda S, Ray CE, Dong Z, Berge M, Hakimi AA, Monette S, Lekaye CL, Koutcher JA, Leslie CS, Creighton CJ, Weinhold N, Lee W, Tickoo SK, Wang Z, Cheng EH, Hsieh JJ.(2017) The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma. Cell Rep.18, 2893-2906. My Events Genetic Loss-of-Function Studies of SETD2 in Tumorigenesis
